after yesterdays agm statement the share price has risen 50% how much upside is left or is this another false dawn?
http://www.alexa.com/data/details/traffic_details/thewellnessshop.co.uk
womans hour link below.
http://www.bbc.co.uk/radio4/womanshour/04/2008_08_mon.shtml

http://www.jmir.org/2006/3/e23/
Journal of Medical Internet Research - Directions for the ...
Cost-effectiveness of computerised cognitive-behavioural therapy for anxiety and depression in primary care: randomised controlled trial. ...

interesting....

Is there anything useful in the pipeline for these guys or are we playing an extended waiting game now to see how their sales do over the next period?

gb waiting game

Mention in Shares mag:
Recomends buying with comment: the risk of delays ( for contracts) remains high and investors will have to patient.

pension thanks for update at least it has been mention in shares now twice in the last few weeks which is better then earlier in the year

I'm tempted but while I have been watching for many months the only product I have seen mentioned is beating the blues.

can anyone say if this is the same product or has it been improved or enhanced in anyway. are there other products the coy sell or in the pipe line ... obviously the principle idea must be a winner but only if the idea is going to be developed to further programs

tipton these are the main products
Beating the Blues
Beating the Blues is a computerised program of cognitive behavioural therapy, endorsed by the National Institute of Health and Clinical Excellence (NICE) as an effective treatment for mild and moderate depression.

The Relief Series
The Relief Series is a range of self-help, online multimedia programs offering education and awareness to help promote mental health and well-being.

Drink and Drug Wise
Drink & Drug Wise is a self-help, on-line multi-media program, that helps people recognise whether they have a need to overcome alcohol and drug misuse, and provides a comprehensive set of tools and techniques to help overcome their problems.

Calm Workplace
Calm Workplace is a Work Related Stress Audit that gives employers of all types and sizes an easy to implement and cost effective way to help meet the Health and Safety Executive's stress management standards.
go to www.ultrasis.com for more information.

this was taken from evo rns this morning
However, the recent negative change in market sentiment towards IPOs and towards
the AIM market in particular, has resulted in a reduction in forecast corporate
finance revenue for the final quarter of 2006. The Group recognises that AIM is
a market suffering from some indigestion, due in part to the constraints of
limited shareholder access and capacity. This may lead to opportunities and some
consolidation. Evolution intends to be ready to take advantage of this and
support the franchise it has built over the last five years.

Ultrasis PLC
01 November 2006


Press release 1 November 2006



Ultrasis launches
www.thewellnessshop.co.uk
online retail arm


Ultrasis plc, the interactive healthcare provider, has launched

www.thewellnessshop.co.uk,
an online retail service designed and developed to
address the growing demand for quality healthcare products and services that
help people to be more active in managing their own health and wellbeing.



By going to
www.thewellnessshop.co.uk
people will be able to find affordable
self-help programmes to tackle some of the more common emotional health problems
that people experience in their lives; including depression, anxiety, stress and
sleep problems.



Interactive healthcare, or more simply the use of computer technology to support
people to get better, has recently been the focus of growing attention with the
recommendation by The National Institute for Health and Clinical Excellence
(NICE) that one of Ultrasis's programs 'Beating the Blues' should be made
available in the NHS to treat mild and moderate depression because of its proven
clinical efficacy and cost effectiveness.



Technical advances have improved considerably the usability and overall consumer
experience available in interactive healthcare. Tension Taker, an interactive
product from Ultrasis aimed at dealing with stress, anxieties, insomnia and IBS,
uses a biofeedback fingertip sensor to teach people how to manage their anxiety
levels.



Nigel Brabbins, Chief Executive of Ultrasis plc, said: 'With more than 120
million people worldwide suffering from depression, the market for self-help
products is growing substantially, as people become more aware of the need to
seek out new ways to solve their health problems. Our own research indicates
that people are looking for both quality and value; the wellness shop' will
provide this, with the added value of being both completely confidential and
available when people need it. We believe that creating 'the wellness shop'
both creates a substantial opportunity for the Company and will contribute
significantly to the emerging positive health and wellbeing agenda.'

http://www.ehiprimarycare.com/news/item.cfm?ID=2243
Free computerised CBT for depression online
06 Nov 2006

Woodie ... many thanks for your most helpful reply .. it will encourage me to keep a closer eye on ULT

no probs glad to help

http://www.mhchoice.csip.org.uk/psychological-therapies/computerised-cognitive-behavioural-therapy-ccbt.html
Computerised Cognitive Behavioural Therapy (cCBT)

ACTION: EMAIL PASA - see para. 3.2



Gateway ref: 7277
1. The purpose of this webpage is to:
Confirm PCT responsibilities in delivering the NICE Technology Appraisal on cCBT
Outline the national procurement process, including the process for delivering a commissioning framework
Set out the funding and contracting arrangements
Update you on the Improving Access to Psychological Therapy (IAPT) programme.



2. cCBT NICE Technology Appraisal: for implementation by 31 March 2007

2.1 In its technological appraisal of February 2006 (TA097), The National Institute for Health and Clinical Excellence (NICE) made the following recommendations about the use of cCBT for the treatment of depression and anxiety:
Beating the Blues for people with mild and moderate depression
FearFighter for people with panic and phobia



2.2 For the delivery of these applications, the Department of Health (DH) has amended the usual requirement for the NHS to fund treatments for NICE technology appraised treatments from 3 to 12 months. Thus, PCTs are expected to be able to offer these cCBT packages by 31 March 2007. This will require PCTs to:
Undertake a local needs assessment
Purchase software licences
Ensure the availability of hardware for the delivery of packages
Ensure that appropriately trained staff are available to supervise delivery
Develop referral protocols



2.3 NICE technology appraisals are binding on the NHS and delivery of this appraisal should be undertaken whilst continuing to achieve financial balance.



3. National Framework Agreement (Tariff)


3.1 The Department is in discussion with the NHS Purchasing and Supply Agency (PASA) to establish a National Framework Agreement covering the two current software packages to enable PCTs/NHS providers to purchase according to a nationally agreed pricing structure.



3.2 We are aware that PCTs have or are about to enter contracts with provider companies. In order to manage this situation by providing best value solutions for yourselves and future purchasing within the scope of the National Framework Agreement it is important that you contact PASA. PASA will provide you with further guidance on the national framework agreement once further discussions have taken place with the software providers.



3.3 We are aware that some PCTs have already entered into contracts with the provider companies. A key aim of the national framework agreement will be to ensure an equitable national tariff. These PCTs are also encouraged to contact PASA.




4. Funding and contracting


4.1 The DH is unable to provide any funding in addition to existing allocations to support the roll-out of these products. However, in delivering the guidance, the cost of the applications may be capitalised. We would therefore advise PCTs to explore any local flexibility to fund this from their capital budgets.



5. cCBT Commissioning Guidelines


5.1 Comprehensive PCT commissioning guidelines will be circulated by Christmas 2006. The guidelines will provide:
Progress on the national tariff
Advice on the hardware, location and product licenses
Positive practice examples to support effective cCBT staffing support and integration with appropriate stepped care psychological therapy service models.



6. Timetable
Christmas 2006 - cCBT Commissioning guidelines distributed to PCTs
31 March 2007 - PCTs have cCBT products in place and the NICE Guidelines are met.


7. Next steps: Delivering Improved Access to Psychological Therapies (IAPT)



7.1 The Government remains committed to improving access to psychological therapies, and we are considering the scope for further developments. This will be considered as part of future service and financial planning by the Department and PCTs



7.3 For the remainder of 2006/07, I would be grateful of your support in working in partnership with your Care Services Improvement Partnership (CSIP) Regional Development Centre to review your local position in the delivery of evidence-based psychological services.



7.4 If you have any further queries about the content of this letter, please do not hesitate to contact your local CSIP Regional Director or James Seward, the national IAPT Programme Director.



Professor Louis Appleby CBE

National Director for Mental Health

john excellent find well done at last there is something in black & white.

Chief executive bulletin: Issue 343, 3 - 9 November 2006
http://www.dh.gov.uk/PublicationsAndStatistics/Bulletins/ChiefExecutiveBulletin/BulletinCE/fs/en?CONTENT_ID=4140442&chk=EXj6ES#6153976
6. NICE technology appraisal on computerised cognitive behavioural therapy (CBT) (Gateway reference number: 7277)
Chief executives are reminded that the NICE technologyappraisal on computerised CBT was published in February 2006 with an implementation waiver of 12 months. This statutory period expires on 31 March 2007. PCTs will need to make this service available from that date. Further guidance to help implementation is at:
http://www.mhchoice.csip.org.uk/psychological-therapies/computerised-cognitive-behavioural-therapy-ccbt.html

comments:- so what do we have in this Ultrasis universe?
a share price that is kept low no matter how much research is done, a letter from the DOH to not only EVERY PCT but also i presume all mental health trusts instructing them to put the Flagship Product BEATING The BLUES in place in the next short period, any other share i have ever followed would have risen enough on the back of that alone to get press coverage.
also from the DOH letter - telling PCT's to get in touch if they have already purchased BTB ...
so just how many have? - we don't know any more because the list of PCT's that had done so, was removed from the Ultrasis web site so why don't the company update it?
as the website is the WINDOW to the WORLD why not list ALL the places BTB is available, that alone would encourage quicker take up by others who have not yet done so.
p.s. with the 'pharmas' losing a lot of support in the states due to the political changes that should mean companies such as Ultrasis have an increased chance of doing deals there.

johndoug i agree the s/price should be higher it has been a disappointment since the last results.with the usa they are being left behind as others are starting to get a foothold in the major comps the longer it is left the harder it will become.

posted by TPIR on advfn
http://www.publications.parliament.uk/cgi-bin/newhtml_hl?DB=semsimple&STEMMER=en&WORDS=new%20technolog%20nh%20ccbt%20beat%20the%20blue&ALL=&ANY=&PHRASE=&CATEGORIES=&SIMPLE=new%20technology%20nhs%20ccbt%20beating%20the%20blues&SPEAKER=&COLOUR=Red&STYLE=s&ANCHOR=muscat_highlighter_first_match&URL=/pa/cm200506/cmhansrd/cm061108/text/61108w0058.htm#muscat_highlighter_first_match
Depression 8 nov 2006

Paul Flynn: To ask the Secretary of State for Health what financial resources have been used to promote non-drug intervention for depression to (a) GP surgeries and (b) relevant patient groups. [100320]

Ms Rosie Winterton: The National Institute for Health and Clinical Excellence (NICE) published clinical guidance for the management of depression in primary and secondary care in 2004. The guidance draws on the best current available evidence for the treatment and management of depression and covers both psychological and drug treatments. Health professionals are expected to take NICE guidance fully into account when exercising their clinical judgement. Different versions of the guidance have been distributed to medical and nursing directors, general practitioners and patient advocacy groups in England and Wales.

Paul Flynn: To ask the Secretary of State for Health what assessment she has made of the effectiveness of (a) the Beating the Blues programme and (b) other non-drug intervention for depression. [100321]

8 Nov 2006 : Column 1813W

Ms Rosie Winterton: We are supporting the increased availability of evidence based psychological therapies through our programme Improving Access to Psychological Therapies, which began in May, and this policy was set out in our 2005 manifesto and in the Our Health, Our Care, Our Say White Paper.

The National Institute for Health and Clinical Excellence (NICE) issued guidance on computerised cognitive behavioural therapies (CCBT) on 22 February 2006, building on its previous guidance on the management and treatment of depression. In reappraising CCBT, NICE has recommended Beating the Blues as an option for the treatment of mild and moderate depression and FearFighter as an option for the treatment of panic and phobia. We are committed to empowering people to take charge of their own treatment and we consider CCBT as an effective vehicle towards this aim.

Clinical guidelines on the management of depression in primary and secondary care were also issued by NICE, in 2004. The guidelines include recommendations for effective drug and psychological treatments for people with mild to moderate depression, anxiety or schizophrenia, and which health care professionals are expected to take fully into account when making decisions about treatment.

http://www.pavpub.com/pavpub/mhtoday/MHTLondon/mht_seminar_guide.pdf.
this is from a link put on the another thread by Ranger & as cgldsmth spotted the 1st paragraph is very interesting.

Mental health in primary care Seminar Room A
Alan Cohen Senior Fellow, Sainsbury Centre for Mental Health

James Seward Choice and Access Programme Director, CSIP/Department of Health

This session will outline the Department of Healths national Improving Access to Psychological Therapies (IAPT) programme,
with a specific focus on steps towards widening access to talking treatments in primary care through use of computerised CBT programmes, in line with the NICE guidelines.

Ben Wright Consultant Psychiatrist in Psychotherapy, East London and The City Mental Health NHS Trust

The Improving Access to Psychological Therapies programme has two demonstration sites, one of which is located in Newham.
The service is provided within the Newham Psychological Treatment Centre (NPTC) and complements existing primary and secondary care services.
This presentation will provide a brief outline of the key ingredients of the NPTC.

write up in shares mag this week

RNS on new BTB deal:

http://www.moneyam.com/action/news/showArticle?id=1705407